Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

694
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

386
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
386
Longitudinal Studies01:26

Longitudinal Studies

247
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
247

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structured, Person-Centred Glycaemic Optimisation Before Surgery: The Manchester IP3D Experience.

Clinical medicine (London, England)·2026
Same author

Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.

Diabetes technology & therapeutics·2026
Same author

Psychosocial etiology and management of chronic pelvic pain in women: a systematic review.

BMC psychology·2026
Same author

Spatiotemporal analysis of climatic and anthropogenic drivers of winter smog in the Indo-Gangetic Plain with a focus on Lahore.

Environmental science and pollution research international·2026
Same author

Multimodal dataset on glucose interpretation, treatment decisions and smartwatch visualisation for type 1 diabetes.

Scientific data·2026
Same author

Temporal gradient analysis of blood glucose responses to non-standard physical activity: a free-living study in type 1 diabetes.

Frontiers in sports and active living·2026

Related Experiment Video

Updated: Sep 12, 2025

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network
09:54

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network

Published on: January 29, 2018

11.1K

A Longitudinal Multimodal Dataset of Type 1 Diabetes.

Ashwaq Alsuhaymi1, Ahmad Bilal1, Daniel Gasca García2

  • 1Department of Computer Science, University of Manchester, Manchester, M13 9PL, UK.

Scientific Data
|August 7, 2025
PubMed
Summary

This study introduces a comprehensive dataset for people with Type 1 Diabetes (PwT1D) to improve glucose management algorithms, especially when automated insulin delivery (AID) systems are unavailable.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Related Experiment Videos

Last Updated: Sep 12, 2025

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network
09:54

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network

Published on: January 29, 2018

11.1K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Area of Science:

  • Endocrinology and Metabolism
  • Biomedical Data Science
  • Medical Informatics

Background:

  • Type 1 Diabetes (T1D) management requires constant blood glucose monitoring and decision-making.
  • Automated Insulin Delivery (AID) systems improve glycemic control but have limited global accessibility.
  • A lack of comprehensive datasets hinders algorithm development for manual diabetes management modes.

Purpose of the Study:

  • To present a detailed, multimodal dataset for Type 1 Diabetes (T1D) management.
  • To support the development of algorithms for scenarios where AID systems are not in use.
  • To facilitate improved diabetes management, particularly in resource-limited settings.

Main Methods:

  • Collected longitudinal, real-world data from 17 participants with T1D over 3 months.
  • Dataset includes blood glucose, insulin dosages, nutritional intake, physical activity, and sleep patterns.
  • Data is multimodal, capturing key physiological and behavioral factors.

Main Results:

  • A comprehensive, publicly available dataset for T1D research is now available.
  • The dataset integrates diverse data streams crucial for diabetes management.
  • Enables the development of advanced algorithms for both manual and automated T1D care.

Conclusions:

  • The released dataset addresses a critical gap in T1D research resources.
  • Facilitates enhanced algorithm development for improved glycemic control.
  • Aims to advance diabetes care accessibility and effectiveness globally.